• No results found

Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial

N/A
N/A
Protected

Academic year: 2020

Share "Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table I . The comparison ofdemographic and clinical characteristics of study participants between groups
Table II . The comparison of ovarian stimulation and cycle outcomes between the study groups

References

Related documents

Aged 51 to 75 years Healthy general condition according to medical history and initial medical examinations (not an exacerbation or hospitalization due to disease in the last 3

No.146, South Ghandi, Vanaq Square, Tehran, Iran City Tehran Province Tehran Postal code 1517964311 Phone +98 21 8879 6003 Email sepideh.salimian.s2@gmail.com Sharing plan.

For accounts that do not meet the non-balance qualifiers: if your average daily balance is $0.01 or more but less than $20,000.00, the first Default Dividend Rate and

[r]

Latin American Studies, The American Journal of Political Science, Latin American Politics and Society, World Politics, The American Political Science Review, Legislative Studies

The effect of powdered green tea enriched with epigallocatchin gallate (EGCG) on some clinical, electrophysiological, biochemical, inflammatory and antioxidant parameters in patients

A Phase III, Randomized,Two armed, Parallel, Double blinded, Active controlled Non-inferiority to evaluate the efficacy of Protection and safety of Papillomavirus vaccine